All the following statements about leukotriene modifers in the management of bronchial asthma are true except: (A) May be used for acute asthma, (B) May be used for exercise induced asthma, (C) Zileuton is leukotriene modifer, (D) May uncover chrug Strauss syndrome
Answer is A. Leukotriene modifers ( monteleukast,zafirulukast) may be considrrco as alternatives to low dose inhaled coicosteroids in patients with mild persistent asthma . Has no role in treating acute severe asthma Ref Harrison 19th edition pg 1673